Aug 12, 2021 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Second Quarter 2021 Financial Results Conference Call. As a reminder, this conference is being recorded.
I will now turn the call over to our host, Corey Davis of LifeSci Advisors. You may begin your conference.
Corey George Davis - LifeSci Advisors, LLC - Relationship Manager
Thank you, operator. Hello, everyone, and welcome to the TFF Pharmaceuticals second quarter 2021 financial and business results conference call.
With me on the line today is Glenn Mattes, President and CEO of TFF; Kirk Coleman, CFO; Dr. Dale Christensen, TFF Director of Clinical Development; Dr. Bill Williams of the University of Texas at Austin and Chris Cano, GFF's Chief Operating Officer.
Announcing our second quarter results is available on the TFF Pharmaceuticals website. Please take a moment to read the disclaimer about forward-looking statements in the release. The earnings release and this teleconference both include forward-looking statements, and these statements are subject
Q2 2021 TFF Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot